When it comes to approaches to mobility, the enterprise has a number of options available. However, life sciences firms find themselves with limited choices – regulatory and security issues affect how they deal with mobile devices inside and outside of the workplace.
This blog post explores a mobility policy known as CLEO (corporate liable, employee owned), and how its benefits, risks and challenges, and best practices would fit in with the life sciences industry.
In today’s competitive environment, companies that are looking to implement new ERP systems must carefully navigate the crowded highway of vendor solutions that are available. Once implemented, the right ERP systems can enhance productivity, encourage growth and increase ROI. First, though, companies have to embark on the journey toward choosing the best ERP system for their businesses.
When mobile devices first began to make their way into the enterprise, they represented uncharted territory for businesses. Many firms still grapple with how to manage, support, and secure these devices. Life sciences companies are no exception.
The enterprise has developed a few approaches to dealing with mobile technologies. One of them is corporate owned, personally enabled (COPE) devices. Read on to learn the benefits, risks and challenges, and best practices for the life sciences industry.
With the rise of mobile devices in the workplace, the use of mobile ERP solutions has risen proportionately. After all, having access to your ERP solution at your fingertips gives you a number of benefits:
But as with all technologies, there are some security risks that you need to be aware of should you decide to implement mobile ERP into your business.
The life sciences industry constantly produces cutting-edge, innovative solutions to help patients live longer, healthier lives. But when it comes to mobile technologies (a cutting-edge field in and of itself), life sciences firms still struggle with the same issues as other companies that aren’t as innovative. Mobile devices present opportunities as well as challenges. Certain mobile technology policies will work better than others. This post discusses the benefits, risks and challenges, and best practices of choose-your-own device (CYOD).
Bringing your own device (BYOD) to work has become commonplace in virtually every field and industry, and life sciences is no exception. For employees, BYOD is enormously freeing – they can use the devices they want when they want them. For IT departments and companies, BYOD can be a nightmare. There are significant security concerns and compliance issues to navigate regarding mobility. Read on to learn how life science firms can balance the benefits of BYOD with the risks and challenges through best practices.
Every developed country has a set of regulations governing Life Science companies that operate or market within its borders. The regulations mainly center on testing, certifications and approvals for products, but the sections most affected by ERP relate to electronic systems and signatures. Most country regulations are very similar to the U.S. Federal Register’s 21 CFR Part 11, although each country has slight variations in requirements or procedures. For example, APEC (Asia Pacific Economic Cooperation) has its LSIF (Life Science Innovation Forum) to help ensure supply chain integrity for health care products and medical devices. Health Canada (HC) regulates medical devices and health care products moving into or out of Canada, and Japan’s Ministry of Health, Labour and Welfare (MHLW) has JPAL for the same purpose.
When it comes to mobile technologies in the workplace, organizations have a few options to manage and secure them. It can be difficult to figure out which approach is right for your company, though. Each offers its own benefits and drawbacks.
One approach is CLEO (corporate liable, employee owned). Read on to learn whether it’s the right option for your firm.
In addition to unique industry requirements related to compliance, Life Sciences companies need ERP systems that are at least as functional and performant as companies in other industries do. Life Sciences companies should ensure that any ERP system they consider has the following characteristics – in addition to the industry specific needs they have in order to operate in a heavily regulated industry.